956 related articles for article (PubMed ID: 33571450)
1. SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.
Lachassinne E; de Pontual L; Caseris M; Lorrot M; Guilluy C; Naud A; Dommergues MA; Pinquier D; Wannepain E; Hausherr E; Jung C; Gajdos V; Cohen R; Zahar JR; Brichler S; Basmaci R; Boelle PY; Bloch-Queyrat C; Aupiais C;
Lancet Child Adolesc Health; 2021 Apr; 5(4):256-264. PubMed ID: 33571450
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.
Tönshoff B; Müller B; Elling R; Renk H; Meissner P; Hengel H; Garbade SF; Kieser M; Jeltsch K; Grulich-Henn J; Euler J; Stich M; Chobanyan-Jürgens K; Zernickel M; Janda A; Wölfle L; Stamminger T; Iftner T; Ganzenmueller T; Schmitt C; Görne T; Laketa V; Olberg S; Plaszczyca A; Cortese M; Bartenschlager R; Pape C; Remme R; Huzly D; Panning M; Weigang S; Giese S; Ciminski K; Ankerhold J; Kochs G; Schwemmle M; Handgretinger R; Niemeyer CM; Engel C; Kern WV; Hoffmann GF; Franz AR; Henneke P; Debatin KM; Kräusslich HG
JAMA Pediatr; 2021 Jun; 175(6):586-593. PubMed ID: 33480966
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study.
Álvarez-Antonio C; Meza-Sánchez G; Calampa C; Casanova W; Carey C; Alava F; Rodríguez-Ferrucci H; Quispe AM
Lancet Glob Health; 2021 Jul; 9(7):e925-e931. PubMed ID: 34022148
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Stringhini S; Wisniak A; Piumatti G; Azman AS; Lauer SA; Baysson H; De Ridder D; Petrovic D; Schrempft S; Marcus K; Yerly S; Arm Vernez I; Keiser O; Hurst S; Posfay-Barbe KM; Trono D; Pittet D; Gétaz L; Chappuis F; Eckerle I; Vuilleumier N; Meyer B; Flahault A; Kaiser L; Guessous I
Lancet; 2020 Aug; 396(10247):313-319. PubMed ID: 32534626
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan.
Valenti L; Bergna A; Pelusi S; Facciotti F; Lai A; Tarkowski M; Lombardi A; Berzuini A; Caprioli F; Santoro L; Baselli G; Ventura CD; Erba E; Bosari S; Galli M; Zehender G; Prati D;
Blood Transfus; 2021 May; 19(3):181-189. PubMed ID: 33539289
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.
Le Vu S; Jones G; Anna F; Rose T; Richard JB; Bernard-Stoecklin S; Goyard S; Demeret C; Helynck O; Escriou N; Gransagne M; Petres S; Robin C; Monnet V; Perrin de Facci L; Ungeheuer MN; Léon L; Guillois Y; Filleul L; Charneau P; Lévy-Bruhl D; van der Werf S; Noel H
Nat Commun; 2021 May; 12(1):3025. PubMed ID: 34021152
[TBL] [Abstract][Full Text] [Related]
7. The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19.
Qin X; Shen J; Dai E; Li H; Tang G; Zhang L; Hou X; Lu M; Wu X; Duan S; Zhang J; Tsoi MF; Jiang P; Li Y
BMC Immunol; 2021 Feb; 22(1):14. PubMed ID: 33596826
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
Hallal PC; Hartwig FP; Horta BL; Silveira MF; Struchiner CJ; Vidaletti LP; Neumann NA; Pellanda LC; Dellagostin OA; Burattini MN; Victora GD; Menezes AMB; Barros FC; Barros AJD; Victora CG
Lancet Glob Health; 2020 Nov; 8(11):e1390-e1398. PubMed ID: 32979314
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of IgM and IgG Antibodies against SARS-CoV-2 in Asymptomatic People in Wuhan: Data from a General Hospital Near South China Seafood Wholesale Market during March to April in 2020.
Ling RJ; Yu YH; He JY; Zhang JX; Xu S; Sun RR; Zhu WC; Chen MF; Li T; Ji HL; Wang HQ
Biomed Environ Sci; 2021 Sep; 34(9):743-749. PubMed ID: 34530966
[TBL] [Abstract][Full Text] [Related]
10. Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study.
Rosado J; Pelleau S; Cockram C; Merkling SH; Nekkab N; Demeret C; Meola A; Kerneis S; Terrier B; Fafi-Kremer S; de Seze J; Bruel T; Dejardin F; Petres S; Longley R; Fontanet A; Backovic M; Mueller I; White MT
Lancet Microbe; 2021 Feb; 2(2):e60-e69. PubMed ID: 33521709
[TBL] [Abstract][Full Text] [Related]
11. Measuring the clustering effect of the SARS-CoV-2 transmission in a school population: a cross-sectional study in a high incidence region.
Severo M; Meireles P; Ribeiro AI; Morais V; Barros H
Sci Rep; 2023 Sep; 13(1):16300. PubMed ID: 37770455
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia.
Banjar A; Al-Tawfiq JA; Alruwaily A; Alserehi H; Al-Qunaibet A; Alaswad R; Almutlaq H; Almudaiheem A; Khojah AT; Alsaif F; Almolad SK; Alqahtani S; AlJurayyan A; Alotaibi A; Almalki S; Abuhaimed Y; Alkhashan A; Alfaifi A; Alabdulkareem K; Jokhdar H; Assiri A; Almudarra S
Int J Infect Dis; 2021 Mar; 104():452-457. PubMed ID: 33465488
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA.
Smith BK; Janowski AB; Danis JE; Harvey IB; Zhao H; Dai YN; Farnsworth CW; Gronowski AM; Roper S; Fremont DH; Wang D
mSphere; 2021 Feb; 6(1):. PubMed ID: 33536325
[TBL] [Abstract][Full Text] [Related]
14. Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021.
Ssuuna C; Galiwango RM; Kankaka EN; Kagaayi J; Ndyanabo A; Kigozi G; Nakigozi G; Lutalo T; Ssekubugu R; Wasswa JB; Mayinja A; Nakibuuka MC; Jamiru S; Oketch JB; Muwanga E; Chang LW; Grabowski MK; Wawer M; Gray R; Anderson M; Stec M; Cloherty G; Laeyendecker O; Reynolds SJ; Quinn TC; Serwadda D
BMC Infect Dis; 2022 Feb; 22(1):174. PubMed ID: 35189840
[TBL] [Abstract][Full Text] [Related]
15. High SARS-CoV-2 Exposure in Rural Southern Mozambique After Four Waves of COVID-19: Community-Based Seroepidemiological Surveys.
de Jesus Á; Ernesto R; Massinga AJ; Nhacolo F; Munguambe K; Timana A; Nhacolo A; Messa A; Massora S; Escola V; Enosse S; Gunjamo R; Funzamo C; Mwenda JM; Okeibunor J; Garcia-Basteiro A; Guinovart C; Mayor A; Mandomando I
Influenza Other Respir Viruses; 2024 Jun; 18(6):e13332. PubMed ID: 38838093
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of antibodies against SARS-CoV-2 in the school community in Campo Grande, state of Mato Grosso do Sul, Brazil, October 2021-November 2022.
Stutz C; Alcantara DMC; Dos Santos CM; Torres JM; Rodrigues R; Marcon GEB; Ferreira EC; Sarti ECFB; de Oliveira TF; Mendes FML; Lemos EF; Demarchi LHF; Lichs GGC; Zardin MCSU; Gonçalves CCM; Guilhermino JF; Perdomo RT; Fernandez ZDC
Front Immunol; 2024; 15():1354786. PubMed ID: 38596680
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
medRxiv; 2020 Oct; ():. PubMed ID: 33140066
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020.
Flamand C; Alves Sarmento C; Enfissi A; Bailly S; Beillard E; Gaillet M; Michaud C; Servas V; Clement N; Perilhou A; Carage T; Musso D; Carod JF; Eustache S; Tourbillon C; Boizon E; James S; Djossou F; Salje H; Cauchemez S; Rousset D
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009945. PubMed ID: 34767549
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of anti-SARS-CoV-2 antibodies among school and daycare children and personnel: protocol for a cohort study in Montreal, Canada.
Zinszer K; McKinnon B; Bourque N; Zahreddine M; Charland K; Papenburg J; Fortin G; Hamelin MÈ; Saucier A; Apostolatos A; Pierce L; Savard-Lamothe A; Carbonneau J; Conrod P; Haley N; Laurin I; Boivin G; De Serres G; Quach C
BMJ Open; 2021 Jul; 11(7):e053245. PubMed ID: 34244288
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study.
Roederer T; Mollo B; Vincent C; Nikolay B; Llosa AE; Nesbitt R; Vanhomwegen J; Rose T; Goyard S; Anna F; Torre C; Fourrey E; Simons E; Hennequin W; Mills C; Luquero FJ
Lancet Public Health; 2021 Apr; 6(4):e202-e209. PubMed ID: 33556328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
